How do stimulant and non-stimulant ADHD medications compare?
Quick answer
Stimulant medications, available as short-acting and long-acting formulations, typically work within hours and are recommended as a first-line option by Canadian ADHD guidelines for most adults. Non-stimulant options take two to six weeks of steady dosing to reach their full effect but are not scheduled as controlled drugs and suit people for whom stimulant side effects or misuse risk are a concern. The right class depends on health history, not personal preference alone.
Stimulant medications act within hours; non-stimulants take weeks
Short-acting and long-acting stimulant formulations generally produce a noticeable effect on the day they are taken, since they act quickly on brain chemical signalling involved in attention and impulse control. Non-stimulant medications work through a different, slower mechanism and typically need two to six weeks of consistent daily dosing before a prescriber can judge their full effect. This difference in speed is one of the biggest practical distinctions between the two classes, and it shapes how each is trialled.
| Feature | Stimulant formulations | Non-stimulant options |
|---|---|---|
| Onset | Same day, often within an hour | Two to six weeks for full effect |
| Dosing pattern | Short-acting: multiple doses a day. Long-acting: usually once daily | Usually once or twice daily, taken every day, including non-school or non-work days |
| Controlled drug status | Scheduled as a controlled drug in Canada | Not scheduled as a controlled drug |
| Typical use | First tried for most adults without contraindications | Used when stimulant side effects, health history, or misuse risk make a stimulant less suitable |
Because a non-stimulant needs weeks to show its effect, a prescriber will usually ask you to stay on a given dose for that full window before deciding whether to adjust it, rather than judging it after only a few days the way a stimulant dose often can be.
Canadian guidelines list stimulants as first-line for most adults
The Canadian ADHD Resource Alliance (CADDRA) Practice Guidelines, the reference document Canadian prescribers use for ADHD care, describe stimulant medications as the treatment most adults and youth try first when there is no reason to avoid them. Non-stimulant options are generally reserved for specific situations rather than offered as an equally weighted first choice for everyone.
- A personal history that makes stimulant misuse a concern
- A strong sensitivity to stimulant-type side effects during a previous trial
- Certain heart conditions identified during a baseline health check
- A preference to avoid a medication that is scheduled as a controlled drug
- A need for smoother, all-day coverage without the peaks and dips some people notice with stimulants
None of these situations rule out ADHD treatment altogether. They simply shift which class a prescriber suggests trying first, and the guidelines still expect a full, fair trial of whichever class is chosen.
Side effects show up on different timelines for each class
Stimulant side effects, most often reduced appetite, trouble sleeping, a faster heart rate, or headache, tend to appear early and change along with the dose, often easing once a stable dose is found. Non-stimulant side effects, such as fatigue, stomach upset, or mild blood pressure changes, tend to build gradually over the weeks it takes the medication to reach full effect, which can make them easier to miss if you're not tracking them.
- Stimulant class: reduced appetite, difficulty sleeping, faster heart rate, headache, irritability as a dose wears off
- Non-stimulant class: fatigue, stomach upset, dry mouth, mild changes in blood pressure
Stimulants carry extra prescribing safeguards in Canada
Because stimulant medications are scheduled as controlled drugs under federal law, pharmacies verify these prescriptions more closely, some provinces track dispensing through systems such as Ontario's Narcotics Monitoring System, and early refills outside a lost or stolen prescription are generally not permitted. Non-stimulant medications move through pharmacies more like other daily prescriptions, without those extra checks, which some people find simpler day to day.
Provincial drug plans also treat the two classes differently for coverage purposes. Ontario residents can check current status for a specific product through the province's medication coverage tool, since listed, exceptional-access, and non-listed status vary by product and can change from one formulary update to the next.
None of this should ever come between you and urgent help. If a stimulant medication is ever used outside how it was prescribed, or if you are in crisis or thinking about harming yourself, call or text 9-8-8, Canada's Suicide Crisis Helpline, or call 911.
Choosing between the two depends on routine and history, not preference alone
The class a prescriber suggests first usually comes down to how quickly symptoms need to be addressed, whether once-daily coverage matters more than fast onset, and whether a person's history makes a controlled drug schedule something to avoid. A trial of either class is followed by scheduled check-ins to confirm it is working and well tolerated before it is considered a good fit, and either class can be adjusted or switched if it isn't.
People considering either class through a virtual clinic can review Finding Focus's online ADHD treatment pathway and the pricing for assessment and ongoing care before booking, and can raise any preference about medication class directly during the assessment.
Common questions
Related questions, answered
Yes. A prescriber can taper off a stimulant and start a non-stimulant, or adjust the stimulant dose or formulation first, depending on the side effect and how long the trial has run. Switching classes usually restarts the weeks-long adjustment period for a non-stimulant.
For many adults, non-stimulant medications produce a smaller average symptom reduction than stimulants, which is one reason guidelines list them second for people without a specific reason to avoid a stimulant. They are still an effective, guideline-recommended option for the situations where they are preferred.
Most provinces require a fresh, dated prescription for each fill of a controlled drug rather than open-ended repeats, and early refills outside a documented lost or stolen prescription are generally not permitted. Non-stimulant prescriptions can often include standard repeats like other daily medications.
For a stimulant, a prescriber can usually judge response within a few days to two weeks per dose step. For a non-stimulant, guidelines call for a full six to eight week trial at an adequate dose before concluding it is not effective, since the benefit builds slowly.
In specific situations a prescriber may combine a stimulant with a non-stimulant, but this is a deliberate clinical decision made after each has been tried individually, not a routine starting approach for a first prescription.
Helpful next steps
References
- 1.CADDRA, Canadian ADHD Practice Guidelines 4.1 View source ↗
- 2.Ontario, Narcotics Monitoring System View source ↗
- 3.Ontario, check medication coverage View source ↗
- 4.Health Canada, travelling with medication that contains a controlled drug View source ↗
This article is for educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional about your individual situation. If you are in crisis or thinking about self-harm, call or text 9-8-8, Canada’s Suicide Crisis Helpline, at any time.
Finding Focus uses AI tools to help research and draft some articles. Every article is edited and fact-checked by the Finding Focus team before publication. See our editorial and medical review policy.
